{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:34:18Z","timestamp":1787009658468,"version":"build-2736575974"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T00:00:00Z","timestamp":1733270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Stichting Het Sclerodermie Fonds"},{"name":"Government of Taiwan"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Cellular senescence and endothelial-to-mesenchymal transition (EndMT) are profibrotic cellular processes involved in systemic sclerosis (SSc), but how they respond to treatment is largely unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Skin biopsies from diffuse cutaneous SSc (dcSSc) patients who underwent either autologous haematopoietic stem cell transplantation (aHSCT) or cyclophosphamide pulse (iv CYC) treatment were collected before and 6\u2009months after randomization in the Autologous Stem Cell Transplantation International Scleroderma trial. The extent of fibrosis, inflammation, senescence, EndMT and tissue remodelling were examined in histopathology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Fourteen pairs of skin biopsies were analysed. Decrease in modified Rodnan skin score was more pronounced in aHSCT-treated patients compared with iv CYC at 6\u2009months (median change \u221214 [IQR \u221216 to \u22129] vs -6 [IQR \u22129 to \u22124], respectively, P = 0.028). Histologically, expression of urokinase-type plasminogen activator receptor (uPAR) on fibroblasts, P21 on vessels and EndMT decreased after treatment in both groups, yet the reduction was more pronounced in the aHSCT group. Poor skin response was associated with high baseline connective tissue growth factor (CTGF) on fibroblasts and low baseline P21 on vessels, with an odds ratio (OR) of 1.43 and 0.41, respectively. Furthermore, poor response was also seen in patients with a rise in CTGF on fibroblasts (OR 1.29) and P21 on vessels (OR 3.02) after treatment, P &amp;lt; 0.001.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Both aHSCT and iv CYC in dcSSc reduced skin thickening clinically and attenuated EndMT, but affected cellular senescence not significantly different. EndMT and uPAR were associated with fibro-remodelling activity, whereas senescence, CTGF, uPAR and vascularity were associated with treatment response.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keae660","type":"journal-article","created":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T15:28:34Z","timestamp":1733239714000},"page":"3957-3963","source":"Crossref","is-referenced-by-count":2,"title":["Dermal cellular senescence and EndMT in patients with systemic sclerosis undergoing cyclophosphamide or aHSCT treatment"],"prefix":"10.1093","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7925-895X","authenticated-orcid":false,"given":"Yu-Hsiang","family":"Chiu","sequence":"first","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht , Utrecht,","place":["The Netherlands"]},{"name":"Division of Rheumatology\/Immunology\/Allergy, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center , Taipei,","place":["Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marijke","family":"van Dijk","sequence":"additional","affiliation":[{"name":"Department of Pathology, University Medical Center Utrecht , Utrecht,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roel","family":"Goldschmeding","sequence":"additional","affiliation":[{"name":"Department of Pathology, University Medical Center Utrecht , Utrecht,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5544-5785","authenticated-orcid":false,"given":"Jacob M","family":"van Laar","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht , Utrecht,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeska K","family":"de Vries-Bouwstra","sequence":"additional","affiliation":[{"name":"The Department of Rheumatology, Leiden University Medical Center , Leiden,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2546-312X","authenticated-orcid":false,"given":"Julia","family":"Spierings","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht , Utrecht,","place":["The Netherlands"]},{"name":"Centre for Rheumatology and Connective Tissue Diseases, UCL Medical School Royal Free Campus , London,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,12,4]]},"reference":[{"key":"2025052703534921600_keae660-B1","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/art.41246","article-title":"Current and future outlook on disease modification and defining low disease activity in systemic sclerosis","volume":"72","author":"Nagaraja","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"2025052703534921600_keae660-B2","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1136\/annrheumdis-2018-213455","article-title":"Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort","volume":"78","author":"Wu","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2025052703534921600_keae660-B3","doi-asserted-by":"crossref","first-page":"652","DOI":"10.7326\/0003-4819-97-5-652","article-title":"D-Penicillamine therapy in progressive systemic sclerosis (scleroderma): a retrospective analysis","volume":"97","author":"Steen","year":"1982","journal-title":"Ann Intern Med"},{"key":"2025052703534921600_keae660-B4","doi-asserted-by":"crossref","first-page":"15002","DOI":"10.1038\/nrdp.2015.2","article-title":"Systemic sclerosis","volume":"1","author":"Allanore","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"2025052703534921600_keae660-B5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11926-020-00920-9","article-title":"Mitochondria, aging, and cellular senescence: implications for scleroderma","volume":"22","author":"Bueno","year":"2020","journal-title":"Curr Rheumatol Rep"},{"key":"2025052703534921600_keae660-B6","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1093\/rheumatology\/keab477","article-title":"Oxidative stress-induced senescence mediates inflammatory and fibrotic phenotypes in fibroblasts from systemic sclerosis patients","volume":"61","author":"Kizilay Mancini","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"2025052703534921600_keae660-B7","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.3899\/jrheum.150088","article-title":"The endothelial-mesenchymal transition in systemic sclerosis is induced by endothelin-1 and transforming growth factor-beta and may be blocked by macitentan, a dual endothelin-1 receptor antagonist","volume":"42","author":"Cipriani","year":"2015","journal-title":"J Rheumatol"},{"key":"2025052703534921600_keae660-B8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/cei.13599","article-title":"Endothelial-to-mesenchymal transition in systemic sclerosis","volume":"205","author":"Di Benedetto","year":"2021","journal-title":"Clin Exp Immunol"},{"key":"2025052703534921600_keae660-B9","doi-asserted-by":"crossref","first-page":"14532","DOI":"10.1038\/ncomms14532","article-title":"Cellular senescence mediates fibrotic pulmonary disease","volume":"8","author":"Schafer","year":"2017","journal-title":"Nat Commun"},{"key":"2025052703534921600_keae660-B10","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3389\/fgene.2018.00247","article-title":"Biomarkers of cellular senescence and skin aging","volume":"9","author":"Wang","year":"2018","journal-title":"Front Genet"},{"key":"2025052703534921600_keae660-B11","doi-asserted-by":"crossref","first-page":"14481","DOI":"10.3390\/ijms241914481","article-title":"Involvement of Epithelial-Mesenchymal Transition (EMT) in autoimmune diseases","volume":"24","author":"Sarrand","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2025052703534921600_keae660-B12","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1136\/jclinpath-2014-202629","article-title":"The utility of ERG, CD31 and CD34 in the cytological diagnosis of angiosarcoma: an analysis of 25 cases","volume":"68","author":"Sullivan","year":"2015","journal-title":"J Clin Pathol"},{"key":"2025052703534921600_keae660-B13","first-page":"1612","article-title":"Association of endothelial to mesenchymal transition and cellular senescence with fibrosis in skin biopsies of systemic sclerosis patients: a cross-sectional study","volume":"41","author":"Chiu","year":"2023","journal-title":"Clin Exp Rheumatol"},{"key":"2025052703534921600_keae660-B14","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s10522-009-9215-5","article-title":"Cyclophosphamide induces premature senescence in normal human fibroblasts by activating MAP kinases","volume":"10","author":"Palaniyappan","year":"2009","journal-title":"Biogerontology"},{"key":"2025052703534921600_keae660-B15","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1056\/NEJMoa055120","article-title":"Cyclophosphamide versus placebo in scleroderma lung disease","volume":"354","author":"Tashkin","year":"2006","journal-title":"N Engl J Med"},{"key":"2025052703534921600_keae660-B16","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S2213-2600(16)30152-7","article-title":"Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial","volume":"4","author":"Tashkin","year":"2016","journal-title":"Lancet Respir Med"},{"key":"2025052703534921600_keae660-B17","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/acr.23282","article-title":"Efficacy of mycophenolate mofetil and oral cyclophosphamide on skin thickness: post hoc analyses from two randomized placebo-controlled trials","volume":"70","author":"Namas","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025052703534921600_keae660-B18","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1001\/jama.2014.6368","article-title":"Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial","volume":"311","author":"van Laar","year":"2014","journal-title":"JAMA"},{"key":"2025052703534921600_keae660-B19","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0140-6736(11)60982-3","article-title":"Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial","volume":"378","author":"Burt","year":"2011","journal-title":"Lancet"},{"key":"2025052703534921600_keae660-B20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa1703327","article-title":"Myeloablative autologous stem-cell transplantation for severe scleroderma","volume":"378","author":"Sullivan","year":"2018","journal-title":"N Engl J Med"},{"key":"2025052703534921600_keae660-B21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.5603\/GP.a2020.0035","article-title":"Presence of human papilloma virus in Caucasian women living in the central Europe diagnosed with vulvar intraepithelial neoplasia","volume":"91","author":"Robenek","year":"2020","journal-title":"Ginekol Pol"},{"key":"2025052703534921600_keae660-B22","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/rheumatology\/kel451","article-title":"Skin involvement in scleroderma\u2014where histological and clinical scores meet","volume":"46","author":"Verrecchia","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"2025052703534921600_keae660-B23","doi-asserted-by":"crossref","first-page":"16878","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci Rep"},{"key":"2025052703534921600_keae660-B24","doi-asserted-by":"crossref","first-page":"17193","DOI":"10.3390\/ijms242417193","article-title":"The role of cellular senescence in cyclophosphamide-induced primary ovarian insufficiency","volume":"6","author":"Xu","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2025052703534921600_keae660-B25","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1136\/annrheumdis-2019-215770","article-title":"Myeloablation followed by autologous stem cell transplantation normalises systemic sclerosis molecular signatures","volume":"78","author":"Assassi","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2025052703534921600_keae660-B26","doi-asserted-by":"crossref","first-page":"e70133","DOI":"10.1371\/journal.pone.0070133","article-title":"p16(INK4A) positively regulates p21(WAF1) expression by suppressing AUF1-dependent mRNA decay","volume":"8","author":"Al-Khalaf","year":"2013","journal-title":"PLoS One"},{"key":"2025052703534921600_keae660-B27","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/nan.12559","article-title":"Expression of p16 and p21 in the frontal association cortex of ALS\/MND brains suggests neuronal cell cycle dysregulation and astrocyte senescence in early stages of the disease","volume":"46","author":"Vazquez-Villasenor","year":"2020","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2025052703534921600_keae660-B28","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41581-022-00601-z","article-title":"Cellular senescence: the good, the bad and the unknown","volume":"18","author":"Huang","year":"2022","journal-title":"Nat Rev Nephrol"},{"key":"2025052703534921600_keae660-B29","doi-asserted-by":"crossref","first-page":"6741","DOI":"10.1128\/MCB.20.18.6741-6754.2000","article-title":"Uncoupling between phenotypic senescence and cell cycle arrest in aging p21-deficient fibroblasts","volume":"20","author":"Dulic","year":"2000","journal-title":"Mol Cell Biol"},{"key":"2025052703534921600_keae660-B30","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1002\/art.39289","article-title":"Dissecting the heterogeneity of skin gene expression patterns in systemic sclerosis","volume":"67","author":"Assassi","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2025052703534921600_keae660-B31","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1136\/annrheumdis-2021-221352","article-title":"Large-scale analysis of longitudinal skin gene expression in systemic sclerosis reveals relationships of immune cell and fibroblast activity with skin thickness and a trend towards normalisation over time","volume":"81","author":"Skaug","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"2025052703534921600_keae660-B32","first-page":"1332","article-title":"P16INK4A-more than a senescence marker","volume":"12","author":"Safwan-Zaiter","year":"2022","journal-title":"Life (Basel)"},{"key":"2025052703534921600_keae660-B33","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1046\/j.0305-1846.2000.287.x","article-title":"Lesion-associated accumulation of uPAR\/CD87- expressing infiltrating granulocytes, activated microglial cells\/macrophages and upregulation by endothelial cells following TBI and FCI in humans","volume":"26","author":"Beschorner","year":"2000","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2025052703534921600_keae660-B34","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41586-020-2403-9","article-title":"Senolytic CAR T cells reverse senescence-associated pathologies","volume":"583","author":"Amor","year":"2020","journal-title":"Nature"},{"key":"2025052703534921600_keae660-B35","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1177\/039463201002300325","article-title":"The plasminogen activator system in fibroblasts from systemic sclerosis","volume":"23","author":"Postiglione","year":"2010","journal-title":"Int J Immunopathol Pharmacol"},{"key":"2025052703534921600_keae660-B36","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1002\/art.20562","article-title":"Matrix metalloproteinase 12-dependent cleavage of urokinase receptor in systemic sclerosis microvascular endothelial cells results in impaired angiogenesis","volume":"50","author":"D'Alessio","year":"2004","journal-title":"Arthritis Rheum"},{"key":"2025052703534921600_keae660-B37","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1136\/annrheumdis-2013-203706","article-title":"Inactivation of urokinase-type plasminogen activator receptor (uPAR) gene induces dermal and pulmonary fibrosis and peripheral microvasculopathy in mice: a new model of experimental scleroderma?","volume":"73","author":"Manetti","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2025052703534921600_keae660-B38","doi-asserted-by":"crossref","first-page":"3926","DOI":"10.1002\/art.22263","article-title":"Domain 1 of the urokinase-type plasminogen activator receptor is required for its morphologic and functional, \u03b22 integrin\u2013mediated connection with actin cytoskeleton in human microvascular endothelial cells: failure of association in systemic sclerosis endothelial cells","volume":"54","author":"Margheri","year":"2006","journal-title":"Arthritis Rheumatism"},{"key":"2025052703534921600_keae660-B39","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1515\/cclm-2015-0079","article-title":"Increased plasma soluble urokinase plasminogen activator receptor levels in systemic sclerosis: possible association with microvascular abnormalities and extent of fibrosis","volume":"53","author":"Legany","year":"2015","journal-title":"Clin Chem Lab Med"},{"key":"2025052703534921600_keae660-B40","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2147\/OARRR.S282612","article-title":"The updated role of ultrasound in assessing dermatological manifestations in systemic sclerosis","volume":"13","author":"Ruaro","year":"2021","journal-title":"Open Access Rheumatol"},{"key":"2025052703534921600_keae660-B41","doi-asserted-by":"crossref","first-page":"e422","DOI":"10.1016\/S2665-9913(23)00100-5","article-title":"The role of skin ultrasound in systemic sclerosis: looking below the surface to understand disease evolution","volume":"5","author":"Lepri","year":"2023","journal-title":"Lancet Rheumatol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keae660\/60951875\/keae660.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/6\/3957\/60951875\/keae660.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/6\/3957\/60951875\/keae660.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T03:54:04Z","timestamp":1748318044000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/6\/3957\/7916572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,4]]},"references-count":41,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,12,4]]},"published-print":{"date-parts":[[2025,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keae660","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,6]]},"published":{"date-parts":[[2024,12,4]]}}}